Report Detail
Global Parkinson Disease Drug Market Growth (Status and Outlook) 2019-2024
- RnM3290033 |
- 09 April, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
According to this study, over the next five years the Parkinson Disease Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Parkinson Disease Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Parkinson Disease Drug market by product type, application, key companies and key regions.
This study considers the Parkinson Disease Drug value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Sinemet-CR
Trastal
COMT Inhibitor
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Parkinson Disease Drug market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Parkinson Disease Drug market by identifying its various subsegments.
Focuses on the key global Parkinson Disease Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Parkinson Disease Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Parkinson Disease Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Parkinson Disease Drug Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Parkinson Disease Drug Market Size 2014-2024
- 2.1.2 Parkinson Disease Drug Market Size CAGR by Region
- 2.2 Parkinson Disease Drug Segment by Type
- 2.2.1 Sinemet-CR
- 2.2.2 Trastal
- 2.2.3 Madopar
- 2.2.4 COMT Inhibitor
- 2.2.5 Other
- 2.3 Parkinson Disease Drug Market Size by Type
- 2.3.1 Global Parkinson Disease Drug Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Parkinson Disease Drug Market Size Growth Rate by Type (2014-2019)
- 2.4 Parkinson Disease Drug Segment by Application
- 2.4.1 Under 40 Years Old
- 2.4.2 40-65 Years Old
- 2.4.3 Above 65 Years Old
- 2.5 Parkinson Disease Drug Market Size by Application
- 2.5.1 Global Parkinson Disease Drug Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Parkinson Disease Drug Market Size Growth Rate by Application (2014-2019)
3 Global Parkinson Disease Drug by Players
- 3.1 Global Parkinson Disease Drug Market Size Market Share by Players
- 3.1.1 Global Parkinson Disease Drug Market Size by Players (2017-2019)
- 3.1.2 Global Parkinson Disease Drug Market Size Market Share by Players (2017-2019)
- 3.2 Global Parkinson Disease Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Parkinson Disease Drug by Regions
- 4.1 Parkinson Disease Drug Market Size by Regions
- 4.2 Americas Parkinson Disease Drug Market Size Growth
- 4.3 APAC Parkinson Disease Drug Market Size Growth
- 4.4 Europe Parkinson Disease Drug Market Size Growth
- 4.5 Middle East & Africa Parkinson Disease Drug Market Size Growth
5 Americas
- 5.1 Americas Parkinson Disease Drug Market Size by Countries
- 5.2 Americas Parkinson Disease Drug Market Size by Type
- 5.3 Americas Parkinson Disease Drug Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Parkinson Disease Drug Market Size by Countries
- 6.2 APAC Parkinson Disease Drug Market Size by Type
- 6.3 APAC Parkinson Disease Drug Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Parkinson Disease Drug by Countries
- 7.2 Europe Parkinson Disease Drug Market Size by Type
- 7.3 Europe Parkinson Disease Drug Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Parkinson Disease Drug by Countries
- 8.2 Middle East & Africa Parkinson Disease Drug Market Size by Type
- 8.3 Middle East & Africa Parkinson Disease Drug Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Parkinson Disease Drug Market Forecast
- 10.1 Global Parkinson Disease Drug Market Size Forecast (2019-2024)
- 10.2 Global Parkinson Disease Drug Forecast by Regions
- 10.2.1 Global Parkinson Disease Drug Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Parkinson Disease Drug Forecast by Type
- 10.8 Global Parkinson Disease Drug Forecast by Application
11 Key Players Analysis
- 11.1 Merck
- 11.1.1 Company Details
- 11.1.2 Parkinson Disease Drug Product Offered
- 11.1.3 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Merck News
- 11.2 Akorn
- 11.2.1 Company Details
- 11.2.2 Parkinson Disease Drug Product Offered
- 11.2.3 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Akorn News
- 11.3 GSK
- 11.3.1 Company Details
- 11.3.2 Parkinson Disease Drug Product Offered
- 11.3.3 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 GSK News
- 11.4 Novartis
- 11.4.1 Company Details
- 11.4.2 Parkinson Disease Drug Product Offered
- 11.4.3 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Novartis News
- 11.5 Boehringer Ingelheim
- 11.5.1 Company Details
- 11.5.2 Parkinson Disease Drug Product Offered
- 11.5.3 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Boehringer Ingelheim News
- 11.6 Teva Pharmaceutical
- 11.6.1 Company Details
- 11.6.2 Parkinson Disease Drug Product Offered
- 11.6.3 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Teva Pharmaceutical News
- 11.7 Abbvie
- 11.7.1 Company Details
- 11.7.2 Parkinson Disease Drug Product Offered
- 11.7.3 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Abbvie News
- 11.8 Kyowa Hakko Kirin Pharma
- 11.8.1 Company Details
- 11.8.2 Parkinson Disease Drug Product Offered
- 11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Kyowa Hakko Kirin Pharma News
- 11.9 Astellas Pharma
- 11.9.1 Company Details
- 11.9.2 Parkinson Disease Drug Product Offered
- 11.9.3 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Astellas Pharma News
- 11.10 Desitin Arzneimittel
- 11.10.1 Company Details
- 11.10.2 Parkinson Disease Drug Product Offered
- 11.10.3 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Desitin Arzneimittel News
- 11.11 Endo Pharmaceuticals
- 11.12 F.Hoffmann-La Roche
- 11.13 H.Lundbeck
- 11.14 Valeant
- 11.15 Apokyn
- 11.16 Orion
- 11.17 Stada Arzneimittel
- 11.18 US WorldMeds
- 11.19 Valeant Pharmaceuticals
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Parkinson Disease Drug . Industry analysis & Market Report on Parkinson Disease Drug is a syndicated market report, published as Global Parkinson Disease Drug Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Parkinson Disease Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
